Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Innovation Pharmaceuticals IPIX
Posted On: 12/17/2016 10:20:47 AM
Post# of 72445
Avatar
Posted By: Drano
Re: someconcerns #29572
That's interesting. It's a twice-a-week IV therapy so is difficult for certain patients to get treatment, plus there is the expense of IV therapy (much more than for something that can be self-administered). Also, it reduces the duration (for instance, from 30 to 10 days), which is good, but it would be better of course if it had efficacy for a higher percentage of patients.

The thing that would concern me with Soligenix's drug is that it is systemic. They say that their studies have shown it doesn't interfere with the cancer treatment, but who really knows with a systemic drug until years later when longer-term survival statistics are available?

I wonder if the one-two punch of treatment with this stuff AND with Bril-OM might prevent people from developing OM at all. We'll have to wait for Bril-OM studies to see what the efficacy is for B-OM. But a combo therapy might be a great thing, unless Bril-OM is super-efficacious for everyone so no combo therapy would be needed.













(0)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site